Alwin D. R. Huitema
ORCID:0000-0003-1939-4639
发表论文 767 篇 · 总被引 18972 次 · h-index 68
代表论文
- Sustained Benefit of Blinatumomab in Infants With KMT2A -Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics (2026 · Journal of Clinical Oncology · 被引 10)
- Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity (2025 · Cardiovascular Research · 被引 6)
- LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib (2025 · Journal of Pharmaceutical and Biomedical Analysis · 被引 5)
- Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs: Achievements, Experiences, Challenges, and the Path Forward (2025 · Therapeutic Drug Monitoring · 被引 4)
- An Overview of Liquid Chromatography–Mass Spectrometry (LC–MS) Methods for the Quantification of Antibody‐Drug Conjugates (2026 · Biomedical Chromatography · 被引 3)
- Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review (2025 · British Journal of Clinical Pharmacology · 被引 3)